A 64-year-old woman having compression fractures in the fourth and fifth thoracic vertebral bodies was diagnosed with multiple myeloma. The results of the initial laboratory investigations were as follows: Hb, 5.6 g/dL; total calcium, 9.6 mg/dL; serum creatinine, 3.6 mg/dL; β2-microglobulin, 29.35 µg/mL; IgG, 11,001 mg/dL; IgA, 5 mg/dL; IgM, 8 mg/dL; and serum monoclonal protein (IgG, lambda), 9.1 g/dL. She was placed on palliative radiation therapy to the thoracic spine and induction chemotherapy, which consisted of thalidomide and dexamethasone. After 3 weeks of chemotherapy, multiple erythematous papules appeared on the anterior chest and upper abdomen; the back and extremities were spared **(A)**. The serum monoclonal protein concentration was 6.6 g/dL. Biopsy of a nodule revealed dense infiltration of plasma cells **(B, C)**, which were positive for CD138 and lambda light chain. Despite salvage treatment consisting of bortezomib and dexamethasone, the patient died of pneumonia 2 months after the diagnosis of cutaneous plasmacytoma. Cutaneous involvement in multiple myeloma is very uncommon and indicates very poor prognosis.
